CardioGenics Holdings (CardioGenics Holdings) LT-Debt-to-Total-Asset : 0.00 (As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. CardioGenics Holdings's long-term debt to total assests ratio for the quarter that ended in Jan. 2016 was 0.00.

CardioGenics Holdings's long-term debt to total assets ratio stayed the same from Jan. 2015 (0.00) to Jan. 2016 (0.00).

CardioGenics Holdings LT-Debt-to-Total-Asset Historical Data

The historical data trend for CardioGenics Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings LT-Debt-to-Total-Asset Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.55

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

CardioGenics Holdings LT-Debt-to-Total-Asset Calculation

CardioGenics Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Oct. 2015 is calculated as

LT Debt to Total Assets (A: Oct. 2015 )	=	Long-Term Debt & Capital Lease Obligation (A: Oct. 2015 )	/	Total Assets (A: Oct. 2015 )
	=	0	/	0.232
	=

CardioGenics Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jan. 2016 is calculated as

LT Debt to Total Assets (Q: Jan. 2016 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jan. 2016 )	/	Total Assets (Q: Jan. 2016 )
	=	0	/	0.558
	=

CardioGenics Holdings (OTCPK:CGNH) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

CardioGenics Holdings LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines